• Kroger (NYSE:KR) pharmacies are expanding access to Eli Lilly's Zepbound KwikPen weight loss medication across their network.
• Beyond Meat is launching its new plant based Beyond Chicken Pieces at more than 2,000 Kroger stores nationwide.

Kroger, through its supermarkets and in store pharmacies, sits at the intersection of food retail and healthcare services. Wider availability of Zepbound at Kroger pharmacies puts a high profile weight loss treatment closer to everyday shoppers, which can be relevant as interest in weight management options remains high. At the same time, plant based products such as Beyond Chicken Pieces keep Kroger's aisles aligned with ongoing demand for alternative proteins.

For investors watching NYSE:KR, these additions highlight how Kroger is using both its pharmacy footprint and grocery shelves to broaden its offer. The developments provide additional data points to track related to prescription traffic, basket composition, and the pace at which new plant based products gain shelf space and shopper attention across a large national chain.

Stay updated on the most important news stories for Kroger by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Kroger.

Quick Assessment

• ⚖️ Price vs Analyst Target: At US$68.07, Kroger trades about 10% below the US$75.45 analyst target, suggesting the price is close to, but below, consensus expectations.
• ✅ Simply Wall St Valuation: Shares are described as trading 39.6% below an estimated fair value, which flags a valuation gap to watch.
• ❌ Recent Momentum: The 30 day return of roughly 5.9% decline shows recent pressure on the share price.

There is only one way to know the right time to buy, sell or hold Kroger. Head to Simply Wall St's company report for the latest analysis of Kroger's Fair Value.

Key Considerations

• 📊 Expanded Zepbound access and new Beyond Chicken Pieces listings show Kroger using its pharmacy and grocery reach to stay relevant in weight management and alternative protein themes.
• 📊 Track script volumes in pharmacies, same store sales, and category trends in plant based products to see whether these launches build traffic and basket size.
• ⚠️ Profit margins of 0.7% versus 1.8% last year and a high level of debt mean investors may want to see that new traffic converts into profitable, not just higher volume, sales.

Dig Deeper

For the full picture including more risks and rewards, check out the complete Kroger analysis. Alternatively, you can check out the community page for Kroger to see how other investors believe this latest news will impact the company's narrative.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.